Deliver Your News to the World

Thomson Reuters Partners with Zynx Health to Integrate Micromedex into ZynxOrder


Comprehensive drug, disease, and lab information accessible through evidence-based order sets

Ann Arbor, MI,—Thomson Reuters and Zynx Health today announced that Thomson Reuters Micromedex® will be integrated into ZynxOrder evidence-based order sets.

This integration pushes Micromedex clinical reference information to the point of care, giving physicians access to comprehensive drug information and disease protocols from their ZynxOrder evidence-based order set. Thomson Reuters will partner with Zynx Health as its source for order set solutions, and Zynx Health will offer Micromedex content as a preferred choice for clinical reference content. Joint customers will have contextual links from their ZynxOrder order sets into the Micromedex content.

“Providing physicians with access to context-specific information is essential for effective clinical decision support,” said Scott Weingarten, MD, MPH, the president and chief executive officer for Zynx Heath. “Thomson Reuters and Zynx Health have each had a long-time, far-reaching commitment to contextual provision of information, so we are very pleased to provide this joint offering.”

This agreement unites Zynx Health’s market leadership in providing evidence-based and experience-based clinical decision support solutions to more than 1,700 hospitals with Thomson Reuters’ market leadership in providing Micromedex evidence-based clinical reference information to more than 3,500 hospitals. “To support physicians in their critical decisions, relevant information needs to be available from within the clinical workflow,” said Thomas Hegelund, executive vice president at Thomson Reuters. “The combination of ZynxOrder order sets and Micromedex evidence-based reference information integrated into the electronic health record and computerized physician order entry environment will give physicians comprehensive clinical information where they need it most.”

Thomson Reuters
Thomson Reuters is the world’s leading source of intelligent information for businesses and professionals. We combine industry expertise with innovative technology to deliver critical information to leading decision makers in the financial, legal, tax and accounting, healthcare and science and media markets, powered by the world’s most trusted news organization. With headquarters in New York and major operations in London and Eagan, Minnesota, Thomson Reuters employs 55,000 people and operates in over 100 countries. For more information, go to

About Zynx Health
Zynx Health, a subsidiary of Hearst Corporation, is the market leader in providing evidence-based and experience-based clinical decision support solutions proven to measurably improve the quality, safety, and efficiency of patient care. Thousands of hospital organizations and providers trust Zynx Health clinical evidence, order sets, plans of care, clinical decision support rules, quality forecasters, and practice guidelines to drive clinical improvements at the point of care and deploy the clinical decision support solutions required to demonstrate meaningful use of electronic health record systems. Collectively, clients have customized and deployed more than 150,000 order sets and plans of care within Zynx Health’s online solutions. Zynx Health partners with First DataBank to provide integrated drug information. To learn more, visit


This news content was configured by WebWire editorial staff. Linking is permitted.

News Release Distribution and Press Release Distribution Services Provided by WebWire.